Asset view · 15 November 2026

European equities: what research is saying

From 183 research houses — 66 asset managers, 53 banks, 38 independent research firms and 26 podcasts. Names are shown to members. See who said what, free →

AI summary of published research · 15 November 2026

European equities caught a bid this week as published research increasingly framed the region as the preferred diversification trade away from US tech concentration.

Several strategy desks moved overweight Continental Europe and the Eurozone, citing earnings growth expected to rival the US in 2027 at materially lower multiples, free cash flow yields near double US levels, and lower AI sensitivity. One published outlook pencilled in 18% STOXX 600 EPS growth in 2026, helped by sector mix, overseas revenue exposure and a softer euro. Switzerland was flagged as a defensive diversifier given its healthcare and staples weighting, with Straumann, Sonova and Lindt cited as quality compounders overshadowed by the AI trade.

The DAX printed a record above 27,000 midweek before softening on Nvidia headlines. Not everything rallied: analysts turned more cautious on luxury, trimmed Diageo on weakening consumer demand, and warned the CAC 40 faces stagflation risk as French 2026 growth forecasts were cut to 0.4%. Commercial aerospace and beauty names were highlighted as pockets of durable growth.

Investment themes on European equities now

Free · by email · no account

The Daily Digest in your inbox

Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.

One-click unsubscribe in every email.